Cutler Group LP Citius Pharmaceuticals, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$0.65 - $0.86 $752 - $995	-1,158 Reduced 98.22%	21 $0
Q2 2023 Jul 18, 2023	SELL	$1.08 - $1.65 $4,182 - $6,390	-3,873 Reduced 76.66%	1,179 $1,000
Q1 2023 May 01, 2023	SELL	$0.78 - $1.42 $312 - $568	-400 Reduced 7.34%	5,052 $5,000
Q3 2022 Oct 25, 2022	BUY	$0.14 - $1.33 $707 - $6,719	5,052 Added 1263.0%	5,452 $6,000
Q1 2022 Apr 14, 2022	SELL	$1.38 - $1.89 $11,338 - $15,528	-8,216 Reduced 95.36%	400 $0

Q4 2021 Jan 18, 2022	BUY	$1.51 - $2.2 $779 - $1,135	516 Added 6.37%	8,616 $13,000
Q3 2021 Oct 26, 2021	BUY	$1.74 - $2.6 $12,876 - $19,240	7,400 Added 1057.14%	8,100 $16,000
Q2 2021 Jul 19, 2021	BUY	$1.51 - $4.23 $1,057 - $2,961	700 New	700 $2,000

26.8M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $99.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.